Sign In
Buy HQY
$86.03
+0.82 (+0.96%)
At Close: Jun 04, 2026
HealthEquity Sets Date to Announce First Quarter Results
04:20pm, Monday, 16'th May 2022
Presentation at Conference Presentation at Conference
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
09:55pm, Thursday, 12'th May 2022 Zacks Investment Research
VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of 6.67% and 67.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q3 Loss, Tops Revenue Estimates
10:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -300% and 5.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clearbridge Small Cap Strategy Portfolio Manager Commentary Q1 2022
04:10am, Friday, 15'th Apr 2022 Seeking Alpha
ClearBridge Small Cap Strategy outperformed its Index benchmark during Q1. Who were the leading detractors and contributors? Click here to find out.
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
02:07pm, Monday, 11'th Apr 2022 Benzinga
Upgrades
Tudor Pickering upgraded the previous rating for EQT Corp (NYSE:EQT) from Hold to Buy. EQT earned $0.41 in the fourth quarter, compared to $0.02 in the year-ago quarter. At the moment, the st
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
02:07pm, Thursday, 07'th Apr 2022 Benzinga
Upgrades
According to Wolfe Research, the prior rating for Cullen/Frost Bankers Inc (NYSE:CFR) was changed from Underperform to Outperform. For the fourth quarter, Cullen/Frost Bankers had an EPS of $
Where HealthEquity Stands With Analysts
04:04pm, Wednesday, 30'th Mar 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on HealthEquity (NASDAQ:HQY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a com
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
02:22pm, Wednesday, 30'th Mar 2022 Benzinga
Upgrades
For Cal-Maine Foods Inc (NASDAQ:CALM), Consumer Edge Research upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Cal-Maine Foods had an EPS of $0.81, compared
HealthEquity Named as One of The Healthiest Workplaces
02:00pm, Tuesday, 29'th Mar 2022 GlobeNewswire Inc.
Company honored with two awards for employee wellness initiatives Company honored with two awards for employee wellness initiatives
HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down
01:34pm, Thursday, 24'th Mar 2022 Zacks Investment Research
HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.
HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down
11:17am, Thursday, 24'th Mar 2022
HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.
A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings, Fed Speakers
09:38am, Wednesday, 23'rd Mar 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped around 250 points in the previous session. Investors are awaiting earnings results from General Mi
HealthEquity (HQY) Q4 2022 Earnings Call Transcript
03:30am, Wednesday, 23'rd Mar 2022 The Motley Fool
HQY earnings call for the period ending December 31, 2021.
HealthEquity, Inc. (HQY) CEO Jon Kessler on Q4 2022 Results - Earnings Call Transcript
01:41am, Wednesday, 23'rd Mar 2022
HealthEquity, Inc. (HQY) CEO Jon Kessler on Q4 2022 Results - Earnings Call Transcript
HealthEquity (HQY) Q4 Earnings Miss Estimates
09:25pm, Tuesday, 22'nd Mar 2022 Zacks Investment Research
HealthEquity (HQY) delivered earnings and revenue surprises of -4.76% and 2.02%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
